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Summary
Objective: Our aims were to translate WOMAC and Lequesne osteoarthritis (OA) indices into Korean (KWOMAC, KLequesne) and confirm
their reliability, validity, and responsiveness.
Design: The WOMAC and Lequesne indices were translated into Korean by three translators and translated back into English by three
different translators. Fifty consecutive patients with OA were asked to rate the comprehensibility of the questions on a 4-point scale. The
comprehensibility (responding with ‘good’ and ‘very good’) ranged from 78% to 99%. Test–retest was performed in another 47 patients with
knee OA. The final 53 patients with knee OA, within the context of a clinical trial of two non-steroidal antiinflammatory drugs for 4 weeks, were
studied to assess the internal consistency, construct validity, and responsiveness of the Korean versions.
Results: The test–retest reliability of the KWOMAC 3 subscales and the KLequesne yielded intraclass correlation coefficients of 0.79–0.89
and 0.87. The Cronbach standardized alphas were 0.81–0.96 and 0.75, respectively. For the construct validity, the correlation coefficients of
both the KWOMAC subscales and the KLequesne with patient pain assessment and patient global assessment were between 0.30 and 0.70
and the KWOMAC subscales correlated with the KLequesne (0.41–0.55). For responsiveness, the KWOMAC and KLequesne scores
significantly improved by 4-week post-treatment compared with pre-treatment; effect size values were between 0.41 and 0.69 for the
KWOMAC subscales and 0.70 for the KLequesne; and the relative efficiency values of the KWOMAC subscales vs the KLequesne were
between 0.87 and 0.90.
Conclusions: The reliability, validity, and responsiveness of the KWOMAC and the KLequesne are confirmed. © 2001 OsteoArthritis
Research Society International
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Assessment of physical function and pain is essential to
evaluate the course of disease and assess treatment
effects in patients with musculoskeletal diseases. A number
of instruments have been developed to measure functional
disability and pain, ranging from physical assessments by
trained assessors to self-administered questionnaire1,2.
Among these instruments, Western Ontario and McMaster
Universities (WOMAC) and Lequesne osteoarthritis (OA)
indices were developed specifically to measure the out-
come of patients with lower extremity arthritis3. They have
been validated, and are probably the two most widely used
instruments for assessing outcomes in patients with OA
of the hip and/or knee4–8. Although translated versions of
the WOMAC and Lequesne indices in several alternative
languages are available6,9,10, no Korean version exists so746far. We adapted the WOMAC and Lequesne indices for the
Korean language and studied their psychometric properties
for research and clinical application.Materials and methodsReceived 27 December 2000; revision requested 1 March 2001;
revision received 12 March 2001; accepted 14 June 2001.
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Three groups of patients with OA were studied: the first
50 consecutive subjects with knee and/or hip OA for
comprehensibility, the second 47 consecutive subjects
with knee OA for test–retest reliability, and the third 53
consecutive subjects with knee OA for internal consistency,
construct validity, and responsiveness (Table I).
The third group study was performed within the context
of a 4-week randomized controlled parallel trial of two
non-steroidal antiinflammatory drugs (NSAIDs) (diclofenac
and celecoxib); a total of 53 consecutive patients (49
women and four men) with knee OA were selected from the
clinical trial and entered in this study. The mean age of the
patients was 59.2±7.2 (43–79) years. The mean duration
of disease was 8.3±6.6 (1–30) years. The mean total
KWOMAC and KLequesne scores were 53.1±17.8 (6–
86) (possible score range: 0–96) and 11.9±2.3 (7–17)
(possible score range: 0–24) respectively (Table I). The
mean VAS of pain was 67.8±15.8 (37–100) mm. The
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The translation of the WOMAC and Lequesne OA in-
dices into Korean (KWOMAC, KLequesne) followed pro-
posed guidelines by Guillemin et al.13 and was done by
three translators and back-translated by three different
translators independently with committee review. For the
translation and back-translation of Lequesne index we
have used the English version of Lequesne index instead of
the original French Lequesne index. Two questions of the
WOMAC were modified for the Korean culture according to
our previous experience; ‘Rising from bed’ and ‘Lying in
bed’ were changed to ‘Rising from a mattress’ and ‘Lying
on a mattress’ since beds are not popular in Korea14.
The WOMAC takes the form of a self-administered
questionnaire and contains 24 questions categorized in
three subscales (Pain, Stiffness, Physical Function)4,5.
Each of questions is rated on either a Likert scale or a
visual analog scale ranging from ‘none’ to ‘extreme’. In this
study we used 5-point Likert scale format: none (0), mild
(1), moderate (2), severe (3), and extreme (4) (5). Likert
scales were used as these perform similarly to visual
analog scale, but lack scaling problems during reproduction
and are easier to score15. Scores for each subscale were
determined by summing the component item scores for
each subscale (possible score range, Pain: 0–20, Stiffness:
0–8, Physical function: 0–68). The final total aggregated
scores (possible score range: 0–96) were determined by
summing the scores for each subscale although their
relative clinical importance has yet to be determined. The
Lequesne has been developed as an interview format and
contains 11 questions6 and we used this interview format. It
directly aggregates symptoms and function (possible score
range: 0–24), which are not graded separately, but can be
categorized in three subscales (Pain, Maximum distance
walked, Activities of daily living).COMPREHENSIBILITY
Fifty patients with OA were asked to rate each question
with regard to whether they understood and were familiar
with the task described (comprehensibility) in reflectingone’s function on a 4-point scale (1: poor; 2: moderate; 3:
good; 4: very good). We regarded questions as compre-
hensible when patients answered three or above.RELIABILITY
Test–retest reliability was performed within additional
group with knee OA since test–retest was not possible due
to clinical trial protocol restriction in the third group. The first
questionnaire was completed by patients themselves while
visiting the clinic and the second done by mail one week
after the visit in the second group of 47 subjects. Internal
consistency was calculated from the results at pre-
treatment in the third group of 53 subjects.CONSTRUCT VALIDITY
Construct validity was assessed in the third group by
comparing the response on the pre-treatment admin-
istration of either the KWOMAC or the KLequesne and
three measures of disease severity and activity: (1) patient
pain assessment using a 100-mm horizontal visual analog
scale (VAS) between 0 (no pain) and 100 (severe pain); (2)
patient global assessment using 5-point Likert scale; and
(3) physician global assessment using 5-point Likert scale.RESPONSIVENESS
Responsiveness of the KWOMAC and the KLequesne
was assessed by following three ways in the third group.
Firstly, KWOMAC and KLequesne scores between pre-
treatment and 4 weeks post-treatment were compared.
Secondly, effect size (ES) of both instruments was calcu-
lated16. Finally, relative efficiency (RE) values of the
KWOMAC vs the KLequesne between pre-treatment and
4 weeks post-treatment were obtained17.Table I








Female:Male 43:7 43:4 49:4
Age (years) 60.1±8.9 55.2±6.9 59.2±7.2
Disease duration (years) 9.0±8.2 7.2±7.1 8.3±6.6
KWOMAC score — 49.2±16.3 53.1±17.8
KLequesne score — 10.5±2.2 11.9±2.3STATISTICS
Test–retest reliability was tested using intraclass corre-
lation coefficients18. Internal consistency was measured by
Cronbach’s alpha19. Spearman rank correlation coefficients
were calculated between either the KWOMAC or the
KLequesne scores and three disease severity variables.
Responsiveness was tested using Wilcoxon’s non-
parametric test20 (for the significance of difference means),
ES, and RE. The ES is the mean change in score divided
by the standard deviation of baseline score. A large ES
indicates high sensitivity to change (0.2: small effect, 0.5:
moderate effect, 0.8: large effect)16,21. The RE is calculatedpsychometric analyses were done by combining data from
the two treatment groups. During the clinical trial, patients
were assessed at four points: screening, pre-treatment,
2 weeks post-treatment, and 4 weeks post-treatment.
All patients met the American College of Rheumatology
criteria for knee and/or hip OA11,12, and were attending an
outpatient clinic at the Hospital for Rheumatic Diseases,
Hanyang University, Seoul, Korea, and gave informed
consent.
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RE (KWOMAC vs KLequesne)=[(tKWOMAC/tKLequesne)2]17.
If an RE is >1, the instrument in the numerator can be
inferred to be the more responsive and efficient tool for
measuring change than the instrument in the denominator.
Conversely, if an RE is <1, the instrument in the denomi-
nator can be inferred to be more responsive. Data were
analysed using the SAS statistical software for personal
computers (SAS 6.12)22.ResultsCOMPREHENSIBILITY
Patients’ ratings of each question were high, with
82–99% (median: 93%) in the KWOMAC and 78–98%
(median: 91%) in the KLequesne of the patients rating each
question as ‘good’ or ‘very good’. Among all questions the
least comprehensible question was ‘Maximum distance
walked’ of the Klequesne (78%).RELIABILITY: TEST–RETEST RELIABILITY
The test–retest reliability yielded 0.79–0.89 of intraclass
correlation coefficients for the KWOMAC subscales and
0.87 for the total KLequesne (Table II).RELIABILITY: INTERNAL CONSISTENCY
Cronbach’s alphas showed strong reliability with stand-
ardized alphas of 0.97 for the total KWOMAC and 0.81–
0.96 for its subscales and 0.75 for the total KLequesne and
0.71–0.85 for its subscales (Table II). The Spearman rank
correlation coefficients between one item and the total and
each subscale score (excluding that item) were from 0.66
to 0.86 in the KWOMAC and from 0.15 to 0.80 in the
KLequesne (Table II).CONSTRUCT VALIDITY
The Spearman rank correlation coefficients of both the
KWOMAC subscales and the KLequesne with patient pain
assessment and patient global assessment were between
0.30 and 0.70, but those with physician global assessment
were between 0.17 and 0.26. The correlation coefficients
of the KWOMAC subscales with the KLequesne were
between 0.41 and 0.55 (Table III).Table II
Reliability of the Korean WOMAC and Lequesne indices
R* Alpha† Correlation‡
Korean WOMAC (Total) 0.95 0.97 0.66–0.86
Pain 0.85 0.89 0.67–0.81
Stiffness 0.79 0.81 0.68
Physical function 0.89 0.96 0.67–0.84
Korean Lequesne (Total) 0.87 0.75 0.15–0.57
Pain 0.76 0.71 0.31–0.61
Maximum distance walked 0.71 0.25 0.15
Daily activity of living 0.80 0.85 0.60–0.80
*Test–retest reliability (intraclass correlation coefficient).
†Internal consistency (Cronbach’s alpha).
‡Correlations between one item and the total and each sub-
scale score excluding that item using Spearman rank correlation
coefficient.Table III
Construct validity of the Korean WOMAC and Lequesne indices
Category
Korean WOMAC Korean Lequesne
VAS PtGATotal Pain Stiffness Function Total Pain Distance Activity
Korean Lequesne
Total 0.59** 0.53** 0.41** 0.55**
Pain 0.56** 0.63** 0.44** 0.48**
Distance 0.10 −0.04 0.02 0.14
Activity 0.44** 0.38** 0.31* 0.41**
VAS 0.59** 0.70** 0.51** 0.49** 0.42** 0.53** −0.11 0.34*
PtGA 0.46** 0.50** 0.36** 0.40** 0.30* 0.24 −0.06 0.36** 0.53**
PhGA 0.26 0.42** 0.36** 0.17 0.25 0.33* −0.21 0.32* 0.48** 0.54**
Numbers represent Spearman rank correlation coefficients. *P<0.05; **P<0.01.
VAS: patient pain assessment using visual analog scale; PtGA: patient global assessment by Likert scale; PhGA: physician global
assessment by Likert scale; Distance: maximum distance walked; Activity: daily activity of living.Table IV
Responsiveness of the Korean WOMAC and Lequesne indices
Difference in mean between
before and after treatment
Effect
size
Korean WOMAC (Total) −11.2* 0.63
Pain −2.6* 0.69
Stiffness −0.8* 0.41
Physical function −7.8* 0.56
Korean Lequesne (Total) −1.7* 0.70
Pain −1.3* 1.05
Maximum distance walked −0.1 0.05
Daily activity of living −0.3 0.08
*P<0.05.RESPONSIVENESS
The total and three subscale scores of the KWOMAC
significantly improved by 4 weeks post-treatment com-
pared with pre-treatment, while the total and ‘Pain’ sub-
scale scores of the KLequesne significantly improved, but
‘Maximum distance walked’ and ‘Daily activity of living’
subscale scores did not improve (Table IV). The ES values
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KLequesne; those of the KLequesne’s ‘Maximum distance
walked’ and ‘Daily activity of living’ subscales were 0.05
and 0.08 respectively (Table IV). The RE values for the total
and three subscales of the KWOMAC vs the total and three
subscales of the KLequesne were between 0.87 and 2.36;
the RE value for the ‘Pain’ subscale of the KWOMAC
versus ‘Pain’ subscale of the KLequesne was 1.0 and the
RE values for the ‘Physical function’ subscale of the
KWOMAC vs ‘Maximum distance walked’ and ‘Daily
activity of living’ subscales of the KLequesne were 2.23 and
1.14 respectively (Table V).Discussion
We have cross-culturally developed Korean language
versions of the WOMAC and the Lequesne and presented
evidence of their comprehensibility, reliability, validity, and
responsiveness. Their comprehensibility was reasonably
high. The least comprehensible question was ‘Maximum
distance walked’. This may be attributable to unfamiliarity
with the concept of ‘distance in metres’ amongst elderly
Koreans since they are not well educated. Although kneel-
ing and squatting are very common activities in Koreans,
we did not consider them in this study since the original
questionnaires do not include such activities. The next
research task will be to identify proper questions and their
validity for the Korean context.
Test–retest correlations of the KWOMAC subscales
(0.79–0.89) and the KLequesne (0.87) were high. The
KWOMAC’s test–retest correlations were better than those
of the original validation study, but similar to that of the
German version4,10. Cronbach’s alphas of the KWOMAC
and the KLequesne were 0.97 and 0.75 respectively for all
items and >0.70 for their subscales, which were similar
to previous work4,10. The internal consistency of the
KWOMAC was better than that of the KLequesne, which
was similar to Stucki et al.’s work10 but all are in the
acceptable range for internal consistency (>0.70)23.
For the construct validity, we have used only subjective
measurements such as patient and physician global
assessments, but not objective measurements such as
range of motion (flexion or extension)5,6, Kellgren and
Lawrence’s radiologic method10. The KWOMAC signifi-
cantly correlated with the KLequesne in the total and
subscale scores except ‘Maximum distance walked’18.
Both instruments significantly correlated with patient pain
assessment and patient global assessment, but not with
physician global assessment. These findings are consistent
with OMERACT III conclusions which show that physicianglobal assessment is considered as less valid than patient
global assessment25.
The effect size of the total KWOMAC is little lower than
that of the total KLequesne and the RE value of the total
KWOMAC vs the total KLequesne was 0.96. However, the
effect size values of three individual KWOMAC subscale
scores were between 0.41 and 0.69, while KLequesne
‘Pain’ subscale effect size value was 1.05, but ‘Maximum
distance walked’ and ‘Activity of daily living’ subscale effect
size values were very small (0.05 and 0.08). The RE values
of three KWOMAC subscales vs ‘Maximum distance
walked’ subscale were over 2. The trend of RE values
between the KWOMAC and the KLequesne was similar to
Bellamy et al.’s work4.
Some limitations require consideration. Firstly, the
English version of Lequesne index has been used instead
of the original French for the cross-cultural adaptation in
Korean since it is quite difficult to find qualified French
translators and back-translators in Korea according to
proposed guideline13. However, it is unlikely to influence
our results because the English Lequesne index has been
validated and widely used. Secondly, our study groups
were relatively small and also might not represent the
whole spectrum of diseases severity in Korea. Finally, a
comparison between the KWOMAC and the KLequesne
was not performed in terms of time necessitation, i.e. how
much time it needs to perform the interview for the
KLequesne and achieve the KWOMAC good realization for
self-administration.
In conclusion, our study suggests that both Korean
versions of the WOMAC and the Lequesne are comprehen-
sible, reliable, valid, and responsive instruments to
measure outcome in patients with knee OA in Korea, and
their psychometric properties are comparable with those of
the original versions.Acknowledgments
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Total 0.96 1.10 2.36 1.31
Pain 0.87 1.00 2.14 1.19
Stiffness 0.88 1.01 2.17 1.21
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